Cargando…
δ-Sarcoglycan-deficient muscular dystrophy: from discovery to therapeutic approaches
Mutations in the δ-sarcoglycan gene cause limb-girdle muscular dystrophy 2F (LGMD2F), an autosomal recessive disease that causes progressive weakness and wasting of the proximal limb muscles and often has cardiac involvement. Here we review the clinical implications of LGMD2F and discuss the current...
Autores principales: | Blain, Alison M, Straub, Volker W |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3156636/ https://www.ncbi.nlm.nih.gov/pubmed/21798091 http://dx.doi.org/10.1186/2044-5040-1-13 |
Ejemplares similares
-
Progressive Muscular Dystrophy in α-Sarcoglycan–deficient Mice
por: Duclos, Franck, et al.
Publicado: (1998) -
Clinical and genetic spectrum of a large cohort of patients with δ-sarcoglycan muscular dystrophy
por: Alonso-Pérez, Jorge, et al.
Publicado: (2021) -
Sarcoglycan Complex: IMPLICATIONS FOR METABOLIC DEFECTS IN MUSCULAR DYSTROPHIES
por: Groh, Séverine, et al.
Publicado: (2009) -
Beta-sarcoglycan-deficient muscular dystrophy presenting as chronic
bronchopneumonia in a young cat
por: Bouillon, Juliette, et al.
Publicado: (2019) -
Leaky ryanodine receptors in β-sarcoglycan deficient mice: a potential common defect in muscular dystrophy
por: Andersson, Daniel C, et al.
Publicado: (2012)